Celularity Correlations
CELUW Stock | USD 0.02 0 20.38% |
The current 90-days correlation between Celularity and Celularity is 0.01 (i.e., Significant diversification). The correlation of Celularity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Celularity Correlation With Market
Very good diversification
The correlation between Celularity and DJI is -0.33 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Celularity and DJI in the same portfolio, assuming nothing else is changed.
Celularity |
Moving against Celularity Stock
0.54 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.54 | ZTS | Zoetis Inc | PairCorr |
0.48 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.46 | HLN | Haleon plc | PairCorr |
0.44 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.43 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.4 | TAK | Takeda Pharmaceutical | PairCorr |
0.39 | RDY | Dr Reddys Laboratories | PairCorr |
0.49 | SMMT | Summit Therapeutics PLC | PairCorr |
0.48 | ANRO | Alto Neuroscience, | PairCorr |
0.45 | AMGN | Amgen Inc | PairCorr |
0.35 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.34 | LTRN | Lantern Pharma | PairCorr |
Related Correlations Analysis
0.2 | 0.08 | -0.25 | 0.13 | CELU | ||
0.2 | -0.17 | -0.18 | 0.42 | EFTRW | ||
0.08 | -0.17 | -0.42 | 0.03 | QSIAW | ||
-0.25 | -0.18 | -0.42 | -0.2 | HUMAW | ||
0.13 | 0.42 | 0.03 | -0.2 | SRZNW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Celularity Stock performing well and Celularity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Celularity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CELU | 7.63 | 0.24 | 0.03 | 0.35 | 9.51 | 11.99 | 149.72 | |||
EFTRW | 20.69 | 1.61 | 0.02 | (0.13) | 25.07 | 67.39 | 201.01 | |||
QSIAW | 10.17 | 2.81 | 0.43 | 0.59 | 5.99 | 25.00 | 133.06 | |||
HUMAW | 5.11 | (0.36) | 0.00 | (0.40) | 0.00 | 12.82 | 44.32 | |||
SRZNW | 20.27 | 4.76 | 0.14 | (0.83) | 18.48 | 82.00 | 179.26 |
Celularity Corporate Management
Carlos Ramirez | SVP Relations | Profile | |
Sharmila MD | Senior Safety | Profile | |
CFA CFA | Chief Officer | Profile | |
Tim Wilk | Senior Operations | Profile | |
Ramji Krishnan | Chief Officer | Profile | |
Bradley Glover | Ex COO | Profile | |
CPA MS | Treasurer | Profile |